KFG Wealth Management’s AbbVie ABBV Stock Holding History

KFG Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Buy	5,670 +1,054	+23%	+$227K	0.16%	72
2026 Q1	$1M	Buy	4,616 +78	+2%	+$17.3K	0.13%	78
2025 Q4	$1.04M	Buy	4,538 +19	+0.4%	+$4.33K	0.14%	78
2025 Q3	$1.05M	Sell	4,519 -146	-3%	-$29.7K	0.15%	74
2025 Q2	$866K	Buy	4,665 +2,846	+156%	+$529K	0.14%	81
2025 Q1	$381K	Buy	1,819 +160	+10%	+$31.1K	0.07%	131
2024 Q4	$295K	Buy	1,659 +23	+1%	+$4.23K	0.06%	147
2024 Q3	$323K	Buy	1,636 +18	+1%	+$3.36K	0.07%	135
2024 Q2	$277K	Sell	1,618 -10	-0.6%	-$1.66K	0.11%	128
2024 Q1	$296K	Buy	1,628 +10	+0.6%	+$1.72K	0.12%	120
2023 Q4	$251K	Sell	1,618 -61	-4%	-$8.89K	0.11%	115
2023 Q3	$250K	Sell	1,679 -4	-0.2%	-$587	0.14%	111
2023 Q2	$227K	Hold	1,683	–	–	0.13%	108
2023 Q1	$274K	Hold	1,683	–	–	0.19%	68
2022 Q4	$272K	Buy	+1,683	New	+$258K	0.28%	59

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KFG Wealth Management's ABBV Position: Q2 2026 in Review

KFG Wealth Management increased its AbbVie (ABBV) stake by 23% in Q2 2026, buying an estimated $227K and bringing the position to 5,670 shares worth $1.43M. The position accounts for 0.16% of the portfolio, ranked #72.

KFG Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

KFG Wealth Management held 5,670 shares of AbbVie worth $1.43M as of Q2 2026.
KFG Wealth Management bought 1,054 AbbVie shares in Q2 2026, an estimated $227K.
AbbVie made up 0.16% of KFG Wealth Management's portfolio in Q2 2026, its #72 holding.
KFG Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KFG Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.